TGA
- Status: approved
🇦🇺 Induction- PF-06480605 150 mg SC Q4W in Australia
Induction- PF-06480605 150 mg SC Q4W (induction-pf-06480605-150-mg-sc-q4w) regulatory status in Australia.
Marketing authorisation
Induction- PF-06480605 150 mg SC Q4W in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Immunology approved in Australia
Frequently asked questions
Is Induction- PF-06480605 150 mg SC Q4W approved in Australia?
Yes. TGA has authorised it.
Who is the marketing authorisation holder for Induction- PF-06480605 150 mg SC Q4W in Australia?
Pfizer is the originator. The local marketing authorisation holder may differ — check the official source linked above.